- £162.81m
- £118.16m
- £12.41m
- 48
- 55
- 56
- 51
Annual balance sheet for Proven Vct, fiscal year end - February 29th, GBP millions except per share, conversion factor applied.
2020 February 29th | 2021 February 28th | 2022 February 28th | 2023 February 28th | 2024 February 29th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | UAS | UAS | UAS | UAS | UAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Cash and Short Term Investments | 36.3 | 37 | 23.5 | 46.6 | 44.6 |
Net Total Receivables | 1.79 | 0.065 | 0.343 | 0.499 | 2.5 |
Prepaid Expenses | |||||
Total Current Assets | 38.7 | 37.3 | 24.1 | 47.3 | 47.5 |
Long Term Investments | |||||
Total Assets | 106 | 127 | 149 | 163 | 169 |
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.932 | 0.433 | 1.32 | 0.783 | 1.25 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.932 | 0.433 | 1.32 | 0.783 | 1.25 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Unrealized Gain / Loss | |||||
Total Equity | 105 | 127 | 148 | 162 | 168 |
Total Liabilities & Shareholders' Equity | 106 | 127 | 149 | 163 | 169 |
Total Common Shares Outstanding |